Type: SARS-CoV-2 spike glycoprotein (S) antigen encoded by RNA and formulated in lipid nanoparticles (LNPs).
Dosage Forms: 2 doses of 30 μg each, administered 21 days apart.
Routes of Administration: Intramuscular
Common Trade Names: Pfizer-BioNTech<unk>  Pfizer<unk>
COVID-19 Vaccine 
Isolation precautions
HIV post-exposure prophylaxis
United States Antibiogram
Vaccination schedule
HIV testing 
Post exposure prophylaxis antibiotics
Crotalidae polyvalent immune Fab 